An excellent post from one of our members and which I think should interest all our members….
Here we go again.
In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants [Paxil, Wellbutrin, Avandia] for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday. The agreement also includes civil penalties for improper marketing of a half-dozen other drugs.
I read this yesterday in the NY Times and although I am happy someone thought this company’s behavior heinous enough to blow the whistle (thank you), I couldn’t help but keep going back to this part of the article:
Prosecutors said the company had tried to win over doctors by paying for trips to Jamaica and Bermuda, as well as spa treatments and hunting excursions. In the case of Paxil, prosecutors claim GlaxoSmithKline employed several tactics aimed at promoting the…
View original post 565 more words